Literature DB >> 1420649

Low plasma gamma-aminobutyric acid levels in male patients with depression.

F Petty1, G L Kramer, C M Gullion, A J Rush.   

Abstract

Plasma levels of gamma-aminobutyric acid (GABA) were significantly lower in males with primary unipolar major depressive disorder than in healthy controls. Although the difference in means between control and symptomatic depressed patient groups was small, the distribution of plasma GABA in the depressed patients was markedly different from controls. Forty percent of depressed patients had plasma GABA levels below those of controls. Plasma GABA levels correlated positively with duration of illness, and negatively with age at onset of the mood disorder and the total Endogenomorphic Symptom Score on the Hamilton Rating Scale. Plasma GABA levels may be a biochemical marker of vulnerability to depression, as opposed to a consequence of the illness. A low GABA condition in depression fits and complements the prevailing biogenic amine hypotheses of depression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420649     DOI: 10.1016/0006-3223(92)90039-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  31 in total

1.  Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide.

Authors:  He Zhu; Beata Karolewicz; Emily Nail; Craig A Stockmeier; Katalin Szebeni; Gregory A Ordway
Journal:  Brain Res       Date:  2006-11-21       Impact factor: 3.252

2.  Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.

Authors:  Gianluigi Guidotti; Francesca Calabrese; Francesca Auletta; Jocelien Olivier; Giorgio Racagni; Judith Homberg; Marco A Riva
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

3.  Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness.

Authors:  Katsumasa Muneoka; Yukihiko Shirayama; Mao Horio; Masaomi Iyo; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2013-04-09       Impact factor: 4.530

Review 4.  Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives.

Authors:  Corey Fee; Mounira Banasr; Etienne Sibille
Journal:  Biol Psychiatry       Date:  2017-06-08       Impact factor: 13.382

Review 5.  Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders.

Authors:  Thomas Prévot; Etienne Sibille
Journal:  Mol Psychiatry       Date:  2020-04-28       Impact factor: 15.992

6.  Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression.

Authors:  Bruno Romeo; Walid Choucha; Philippe Fossati; Jean-Yves Rotge
Journal:  J Psychiatry Neurosci       Date:  2017-10-02       Impact factor: 6.186

7.  The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.

Authors:  Vilma Gabbay; Leonard Liebes; Yisrael Katz; Songtao Liu; Sandra Mendoza; James S Babb; Rachel G Klein; Oded Gonen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-09-21       Impact factor: 5.067

8.  Enhanced visual motion perception in major depressive disorder.

Authors:  Julie D Golomb; Jenika R B McDavitt; Barbara M Ruf; Jason I Chen; Aybala Saricicek; Kathleen H Maloney; Jian Hu; Marvin M Chun; Zubin Bhagwagar
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

9.  Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.

Authors:  Rebecca B Price; Dikoma C Shungu; Xiangling Mao; Paul Nestadt; Chris Kelly; Katherine A Collins; James W Murrough; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

10.  Fluoxetine partly exerts its actions through GABA: a neurochemical evidence.

Authors:  M Zafer Gören; Esra Küçükibrahimoglu; Kemal Berkman; Berna Terzioglu
Journal:  Neurochem Res       Date:  2007-05-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.